应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
VERU Veru Inc.
已收盘 07-14 16:00:00 EDT
0.6045
+0.0040
+0.67%
盘后
0.6060
+0.0015
+0.25%
19:59 EDT
最高
0.6150
最低
0.5930
成交量
83.74万
今开
0.6000
昨收
0.6005
日振幅
3.66%
总市值
8,861万
流通市值
7,604万
总股本
1.47亿
成交额
50.59万
换手率
0.67%
流通股本
1.26亿
市净率
4.21
ROE
-93.86%
每股收益
-0.25
52周最高
1.42
52周最低
0.4500
市盈率
-2.43
股息
0.00
股息收益率
0.00
ROA
-49.03%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Veru表示,节省肌肉的肥胖药物安全进入第3阶段试验Muscle-sparing obesity drug safe for Phase 3 trial, Veru says
动脉网 · 05-28
Veru表示,节省肌肉的肥胖药物安全进入第3阶段试验Muscle-sparing obesity drug safe for Phase 3 trial, Veru says
Veru Inc.2025财年第一财季实现净利润-7.85百万美元,同比增加21.73%
市场透视 · 05-17
Veru Inc.2025财年第一财季实现净利润-7.85百万美元,同比增加21.73%
Veru Inc.盘中异动 快速跳水5.70%报0.514美元
市场透视 · 04-15
Veru Inc.盘中异动 快速跳水5.70%报0.514美元
“减脂不减肌”:药企竞逐下一代减肥药新突破
老虎资讯综合 · 02-20
“减脂不减肌”:药企竞逐下一代减肥药新突破
Veru Inc.盘中异动 急速上涨5.05%报0.579美元
市场透视 · 02-19
Veru Inc.盘中异动 急速上涨5.05%报0.579美元
Veru Inc.盘中异动 急速上涨5.06%
市场透视 · 02-18
Veru Inc.盘中异动 急速上涨5.06%
Veru Inc.盘中异动 股价大跌5.09%报0.522美元
市场透视 · 02-13
Veru Inc.盘中异动 股价大跌5.09%报0.522美元
Veru 第一季度调整后每股收益$(0.07) 超过预期$(0.08)
财报速递 · 02-13
Veru 第一季度调整后每股收益$(0.07) 超过预期$(0.08)
Veru(VERU.US):2025年Q1财报实现营收0美元,前值为214.1万美元,预期值为298万美元;每股收益为-0.07美元,前值为-0.08美元,预期值为-0.08美元。
金融界 · 02-13
Veru(VERU.US):2025年Q1财报实现营收0美元,前值为214.1万美元,预期值为298万美元;每股收益为-0.07美元,前值为-0.08美元,预期值为-0.08美元。
Veru公司2025财年第一季度GAAP每股收益为$(0.06),好于预期$(0.07),现金及现金等价物为2660万美元
财报速递 · 02-13
Veru公司2025财年第一季度GAAP每股收益为$(0.06),好于预期$(0.07),现金及现金等价物为2660万美元
Veru Inc.盘中异动 股价大跌5.15%
市场透视 · 02-11
Veru Inc.盘中异动 股价大跌5.15%
Veru Inc.盘中异动 快速跳水5.18%
市场透视 · 02-07
Veru Inc.盘中异动 快速跳水5.18%
Veru Inc.盘中异动 急速上涨5.00%报0.588美元
市场透视 · 02-05
Veru Inc.盘中异动 急速上涨5.00%报0.588美元
Veru Inc.盘中异动 股价大跌5.00%
市场透视 · 02-04
Veru Inc.盘中异动 股价大跌5.00%
Veru Inc.盘中异动 股价大涨5.27%
市场透视 · 02-03
Veru Inc.盘中异动 股价大涨5.27%
Veru Inc.盘中异动 股价大跌5.10%
市场透视 · 01-30
Veru Inc.盘中异动 股价大跌5.10%
Veru Inc.盘中异动 早盘快速拉升5.53%
市场透视 · 01-29
Veru Inc.盘中异动 早盘快速拉升5.53%
Veru Inc.盘中异动 股价大涨5.10%
市场透视 · 01-28
Veru Inc.盘中异动 股价大涨5.10%
Veru Inc.盘中异动 急速下挫46.27%报0.650美元
市场透视 · 01-27
Veru Inc.盘中异动 急速下挫46.27%报0.650美元
Veru Inc.盘中异动 股价大涨5.70%
市场透视 · 01-24
Veru Inc.盘中异动 股价大涨5.70%
加载更多
公司概况
公司名称:
Veru Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Veru Inc.成立于1971年。是一家临床后期生物制药公司,专注于开发治疗代谢性疾病、肿瘤学、ARDS的新药。该公司的药物开发计划包括两个晚期新化学实体,enobosarm和sabizabulin。
发行价格:
--
{"stockData":{"symbol":"VERU","market":"US","secType":"STK","nameCN":"Veru Inc.","latestPrice":0.6045,"timestamp":1752523200000,"preClose":0.6005,"halted":0,"volume":837370,"hourTrading":{"tag":"盘后","latestPrice":0.606,"preClose":0.6045,"latestTime":"19:59 EDT","volume":29294,"amount":17634.8142,"timestamp":1752537593992},"delay":0,"floatShares":125783353,"shares":146583920,"eps":-0.248294,"marketStatus":"已收盘","change":0.004,"latestTime":"07-14 16:00:00 EDT","open":0.6,"high":0.615,"low":0.593,"amount":505862.54398749996,"amplitude":0.036636,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.248294,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752566400000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.6005,"preHourTrading":{"tag":"盘前","latestPrice":0.5928,"preClose":0.6005,"latestTime":"09:26 EDT","volume":17422,"amount":10435.1821676,"timestamp":1752499568598},"postHourTrading":{"tag":"盘后","latestPrice":0.606,"preClose":0.6045,"latestTime":"19:59 EDT","volume":29294,"amount":17634.8142,"timestamp":1752537593992},"volumeRatio":0.548607,"impliedVol":1.6004,"impliedVolPercentile":0.42},"requestUrl":"/m/hq/s/VERU","defaultTab":"news","newsList":[{"id":"2539701174","title":"Veru表示,节省肌肉的肥胖药物安全进入第3阶段试验Muscle-sparing obesity drug safe for Phase 3 trial, Veru says","url":"https://stock-news.laohu8.com/highlight/detail?id=2539701174","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539701174?lang=zh_cn&edition=full","pubTime":"2025-05-28 23:56","pubTimestamp":1748447760,"startTime":"0","endTime":"0","summary":"Dive Brief:简报:Veru’s muscle-preserving obesity drug enobosarm, when combined with Novo Nordisk’s Wegovy, may have less gastrointestinal side effects at the dose planned for pivotal testing than Wegovy alone, according to safety results from a Phase 2 clinical trial the根据一项二期临床试验的安全性结果,Veru的肌肉保护型减肥药Enobosarm与诺和诺德的Wegovy联合使用时,在计划用于关键测试的剂量下,可能比单独使用Wegovy的胃肠道副作用更少。Veru shares rose significantly in morning trading Wednesday, although at around 60 cents a share they remain well below the $1.28 hit before release of周三早盘交易中,Veru的股价显著上涨,尽管每股约60美分的价格仍远低于发布前的1.28美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505282356509768b0a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505282356509768b0a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","VERU","BK4557","BK4183","BK4007"],"gpt_icon":0},{"id":"2536358470","title":"Veru Inc.2025财年第一财季实现净利润-7.85百万美元,同比增加21.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536358470","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536358470?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497610,"startTime":"0","endTime":"0","summary":"5月18日,Veru Inc.公布财报,公告显示公司2025财年第一财季净利润为-7.85百万美元,同比增加21.73%;其中营业收入为0.00美元,每股基本收益为-0.05美元。从资产负债表来看,Veru Inc.总负债11.62百万美元,其中短期债务747951.00美元,资产负债比为2.82,流动比率为3.81。机构评级:截至2025年5月18日,当前有3家机构对Veru Inc.目标价做出预测,其中目标均价为3.33美元,其中最低目标价为3.00美元,最高目标价为4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000020a6e2d798&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000020a6e2d798&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERU"],"gpt_icon":0},{"id":"2527429581","title":"Veru Inc.盘中异动 快速跳水5.70%报0.514美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527429581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527429581?lang=zh_cn&edition=full","pubTime":"2025-04-16 02:04","pubTimestamp":1744740285,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日02时04分,Veru Inc.股票出现波动,股价快速下跌5.70%。截至发稿,该股报0.514美元/股,成交量41.1024万股,换手率0.28%,振幅9.48%。Veru Inc.股票所在的生物技术行业中,整体跌幅为0.59%。其相关个股中,Mural Oncology Plc、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大,Mural Oncology Plc、Dogwood Therapeutics, Inc.、Metavia Inc.较为活跃,换手率分别为1428.72%、976.60%、262.78%,振幅较大的相关个股有Skye Bioscience, Inc.、Mural Oncology Plc、Dogwood Therapeutics, Inc.,振幅分别为171.53%、97.08%、91.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041602044594d65e43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041602044594d65e43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VERU","BK4183","BK4557","BK4584"],"gpt_icon":0},{"id":"1166835000","title":"“减脂不减肌”:药企竞逐下一代减肥药新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1166835000","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166835000?lang=zh_cn&edition=full","pubTime":"2025-02-20 17:58","pubTimestamp":1740045485,"startTime":"0","endTime":"0","summary":"罗氏计划今年启动中期试验,将其与自研GLP-1减肥候选药CT-388联用。BiohavenBiohaven在一项早期肥胖试验中评估其靶向肌肉生长抑制素的药物taldefgrobep alfa。该药虽未改善脊髓性肌萎缩症患者的运动功能,但减少了总体脂肪量,并在去脂体重和骨密度方面优于安慰剂。公司将在男性肥胖患者的早期研究中评估安全性,数据预计2025年一季度公布。","market":"us","thumbnail":"https://community-static.tradeup.com/news/f13f2eb23080965f77e2c21530116841","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/f13f2eb23080965f77e2c21530116841"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"“减脂不减肌”:药企竞逐下一代减肥药新突破","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KROS","AZN","REGN","LLY","VERU","SRRK","ELAB","RHHBY","ARWR"],"gpt_icon":1},{"id":"2512827224","title":"Veru Inc.盘中异动 急速上涨5.05%报0.579美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512827224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512827224?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:56","pubTimestamp":1739984170,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时56分,Veru Inc.股票出现波动,股价急速上涨5.05%。截至发稿,该股报0.579美元/股,成交量53.3728万股,换手率0.36%,振幅5.05%。Veru Inc.股票所在的生物技术行业中,整体涨幅为0.46%。Veru Inc.公司简介:Veru Inc是一家生物制药公司,拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220005610988b48c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220005610988b48c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","BK4557","VERU","BK4183"],"gpt_icon":0},{"id":"2512516732","title":"Veru Inc.盘中异动 急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512516732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512516732?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:32","pubTimestamp":1739896345,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时32分,Veru Inc.股票出现波动,股价急速上涨5.06%。截至发稿,该股报0.569美元/股,成交量124.164万股,换手率0.85%,振幅8.78%。Veru Inc.股票所在的生物技术行业中,整体涨幅为0.67%。Veru Inc.公司简介:Veru Inc是一家生物制药公司,拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190032259627ac39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190032259627ac39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","VERU","BK4557","BK4584"],"gpt_icon":0},{"id":"2511652650","title":"Veru Inc.盘中异动 股价大跌5.09%报0.522美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511652650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511652650?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457068,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分,Veru Inc.股票出现波动,股价大幅下挫5.09%。截至发稿,该股报0.522美元/股,成交量152.217万股,换手率1.04%,振幅1.96%。Veru Inc.股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Tc Biopharm Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃,换手率分别为970.17%、765.03%、89.78%,振幅较大的相关个股有Enliven Therapeutics, Inc.、Rezolute, Inc.、Edesa Biotech, Inc.,振幅分别为7.80%、4.53%、4.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322310998842b63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322310998842b63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","VERU","BK4557","BK4584"],"gpt_icon":0},{"id":"1104004542","title":"Veru 第一季度调整后每股收益$(0.07) 超过预期$(0.08)","url":"https://stock-news.laohu8.com/highlight/detail?id=1104004542","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104004542?lang=zh_cn&edition=full","pubTime":"2025-02-13 19:42","pubTimestamp":1739446968,"startTime":"0","endTime":"0","summary":"Veru 报告季度每股亏损$,超过了分析师一致预期的每股亏损$,超出12.5%。相比去年同期每股亏损$,增加了12.5%。以上内容来自Benzinga Earnings专栏,原文如下:Veru reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 12.5 percent. This is a 12.5 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERU"],"gpt_icon":0},{"id":"2511823546","title":"Veru(VERU.US):2025年Q1财报实现营收0美元,前值为214.1万美元,预期值为298万美元;每股收益为-0.07美元,前值为-0.08美元,预期值为-0.08美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511823546","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511823546?lang=zh_cn&edition=full","pubTime":"2025-02-13 19:42","pubTimestamp":1739446935,"startTime":"0","endTime":"0","summary":"Veru(VERU.US):2025年Q1财报实现营收0美元,前值为214.1万美元,预期值为298万美元;每股收益为-0.07美元,前值为-0.08美元,预期值为-0.08美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/13194248146640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VERU"],"gpt_icon":0},{"id":"1157057844","title":"Veru公司2025财年第一季度GAAP每股收益为$(0.06),好于预期$(0.07),现金及现金等价物为2660万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157057844","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157057844?lang=zh_cn&edition=full","pubTime":"2025-02-13 19:33","pubTimestamp":1739446411,"startTime":"0","endTime":"0","summary":"Veru公司公布季度每股亏损$,较分析师普遍预期的$高出14.29%。与去年同期的每股亏损$相比,增长了25%。以上内容来自Benzinga Earnings专栏,原文如下:Veru reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 14.29 percent. This is a 25 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Veru公司2025财年第一季度GAAP每股收益为$(0.06),好于预期$(0.07),现金及现金等价物为2660万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERU"],"gpt_icon":0},{"id":"2510380942","title":"Veru Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380942?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:50","pubTimestamp":1739285410,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时50分,Veru Inc.股票出现异动,股价大幅下挫5.15%。Veru Inc.股票所在的生物技术行业中,整体跌幅为1.52%。其相关个股中,Ocean Biomedical, Inc.、Dominari Holdings Inc.、Lipella Pharmaceuticals Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2370.36%、645.02%、277.64%,振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.,振幅分别为40.26%、33.04%、33.02%。Veru Inc.公司简介:Veru Inc是一家生物制药公司,拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211225010abcb0a77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211225010abcb0a77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","BK4584","VERU","BK4183"],"gpt_icon":0},{"id":"2509614773","title":"Veru Inc.盘中异动 快速跳水5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509614773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509614773?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:30","pubTimestamp":1738956645,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时30分,Veru Inc.股票出现异动,股价快速下挫5.18%。截至发稿,该股报0.551美元/股,成交量136.703万股,换手率0.93%,振幅8.33%。Veru Inc.股票所在的生物技术行业中,整体跌幅为0.65%。Veru Inc.公司简介:Veru Inc是一家生物制药公司,拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208033045a23d60ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208033045a23d60ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","BK4557","VERU","BK4183"],"gpt_icon":0},{"id":"2509565352","title":"Veru Inc.盘中异动 急速上涨5.00%报0.588美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509565352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509565352?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:33","pubTimestamp":1738787622,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时33分,Veru Inc.股票出现波动,股价大幅拉升5.00%。截至发稿,该股报0.588美元/股,成交量251.646万股,换手率1.72%,振幅8.75%。Veru Inc.股票所在的生物技术行业中,整体涨幅为2.25%。Veru Inc.公司简介:Veru Inc是一家生物制药公司,拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206043342abc3c826&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206043342abc3c826&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERU","BK4584","BK4557","BK4183"],"gpt_icon":0},{"id":"2509286491","title":"Veru Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509286491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509286491?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:57","pubTimestamp":1738702628,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时57分,Veru Inc.股票出现异动,股价快速下跌5.00%。Veru Inc.股票所在的生物技术行业中,整体涨幅为1.46%。其相关个股中,Mink Therapeutics, Inc.、Cingulate Inc C/Wts 10/12/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为1968.51%、997.59%、592.78%,振幅较大的相关个股有Azitra Inc、Mink Therapeutics, Inc.、Omega Therapeutics, Inc.,振幅分别为123.99%、80.03%、60.13%。Veru Inc.公司简介:Veru Inc是一家生物制药公司,拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205045708abc26e47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205045708abc26e47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","VERU","BK4183","BK4557"],"gpt_icon":0},{"id":"2508639144","title":"Veru Inc.盘中异动 股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508639144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508639144?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:52","pubTimestamp":1738594339,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时52分,Veru Inc.股票出现波动,股价快速拉升5.27%。截至发稿,该股报0.585美元/股,成交量57.5427万股,换手率0.39%,振幅8.10%。Veru Inc.股票所在的生物技术行业中,整体跌幅为0.54%。Veru Inc.公司简介:Veru Inc是一家生物制药公司,拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203225219abc10c20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203225219abc10c20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERU","BK4183","BK4584","BK4557"],"gpt_icon":0},{"id":"2507562478","title":"Veru Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507562478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507562478?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:37","pubTimestamp":1738247823,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时37分,Veru Inc.股票出现异动,股价大幅跳水5.10%。截至发稿,该股报0.580美元/股,成交量51.2556万股,换手率0.35%,振幅5.56%。Veru Inc.股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大,Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃,换手率分别为789.58%、134.25%、112.73%,振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Kazia Therapeutics Limited、Tectonic Therapeutic, Inc.,振幅分别为28.90%、28.25%、24.49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302237039876b255&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302237039876b255&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERU","BK4584","BK4557","BK4183"],"gpt_icon":0},{"id":"2507631266","title":"Veru Inc.盘中异动 早盘快速拉升5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507631266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507631266?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:31","pubTimestamp":1738161066,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时31分,Veru Inc.股票出现波动,股价大幅上涨5.53%。截至发稿,该股报0.550美元/股,成交量48.0583万股,换手率0.33%,振幅0.02%。Veru Inc.股票所在的生物技术行业中,整体涨幅为0.08%。Veru Inc.公司简介:Veru Inc是一家生物制药公司,拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223106a23366cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223106a23366cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERU","BK4584","BK4183","BK4557"],"gpt_icon":0},{"id":"2506514939","title":"Veru Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506514939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506514939?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074693,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分,Veru Inc.股票出现异动,股价大幅上涨5.10%。截至发稿,该股报0.668美元/股,成交量52.5319万股,换手率0.36%,振幅1.09%。Veru Inc.股票所在的生物技术行业中,整体涨幅为0.01%。Veru Inc.公司简介:Veru Inc是一家生物制药公司,拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822313498756b68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822313498756b68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERU","BK4557","BK4584","BK4183"],"gpt_icon":0},{"id":"2506303289","title":"Veru Inc.盘中异动 急速下挫46.27%报0.650美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506303289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506303289?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:31","pubTimestamp":1737988311,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时31分,Veru Inc.股票出现异动,股价大幅下挫46.27%。截至发稿,该股报0.650美元/股,成交量1171.29万股,换手率8.00%,振幅2.73%。Veru Inc.股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,Akero Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、89Bio, Inc.涨幅较大,Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃,换手率分别为718.39%、39.81%、34.99%,振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Akero Therapeutics, Inc.、Biocardia, Inc.,振幅分别为11.62%、11.19%、10.50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223151a2316abe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223151a2316abe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERU","BK4557","BK4183","BK4584"],"gpt_icon":0},{"id":"2505865264","title":"Veru Inc.盘中异动 股价大涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505865264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505865264?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:30","pubTimestamp":1737729046,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时30分,Veru Inc.股票出现波动,股价急速拉升5.70%。截至发稿,该股报1.35美元/股,成交量60.4576万股,换手率0.41%,振幅0.78%。Veru Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Veru Inc.公司简介:Veru Inc是一家生物制药公司,拥有治疗代谢性疾病、肿瘤学和急性呼吸窘迫综合征的药物开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223046abb74e0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223046abb74e0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERU","BK4183","BK4557","BK4584"],"gpt_icon":0}],"profile":{"websiteUrl":"http://verupharma.com","stockEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.1071},{"period":"3month","weight":0.1065},{"period":"6month","weight":-0.2319},{"period":"1year","weight":-0.3553},{"period":"ytd","weight":-0.0769}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Veru Inc.成立于1971年。是一家临床后期生物制药公司,专注于开发治疗代谢性疾病、肿瘤学、ARDS的新药。该公司的药物开发计划包括两个晚期新化学实体,enobosarm和sabizabulin。","yearOnYearQuotes":[{"month":1,"riseRate":0.5625,"avgChangeRate":-0.008681},{"month":2,"riseRate":0.4375,"avgChangeRate":0.064144},{"month":3,"riseRate":0.375,"avgChangeRate":-0.037891},{"month":4,"riseRate":0.5625,"avgChangeRate":0.132922},{"month":5,"riseRate":0.5,"avgChangeRate":0.006227},{"month":6,"riseRate":0.3125,"avgChangeRate":-0.035854},{"month":7,"riseRate":0.470588,"avgChangeRate":0.000988},{"month":8,"riseRate":0.4375,"avgChangeRate":0.018618},{"month":9,"riseRate":0.375,"avgChangeRate":-0.020149},{"month":10,"riseRate":0.375,"avgChangeRate":-0.017773},{"month":11,"riseRate":0.5,"avgChangeRate":-0.006113},{"month":12,"riseRate":0.25,"avgChangeRate":0.079178}],"exchange":"NASDAQ","name":"Veru Inc.","nameEN":"Veru Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Veru Inc.(VERU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Veru Inc.(VERU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Veru Inc.,VERU,Veru Inc.股票,Veru Inc.股票老虎,Veru Inc.股票老虎国际,Veru Inc.行情,Veru Inc.股票行情,Veru Inc.股价,Veru Inc.股市,Veru Inc.股票价格,Veru Inc.股票交易,Veru Inc.股票购买,Veru Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Veru Inc.(VERU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Veru Inc.(VERU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}